|
In this interview, Dr. Salim Yusuf talks about the Heart Outcomes Prevention Evaluation
 (HOPE)
Study. According to data from Essential
Science Indicators , Dr. Yusuf's
paper "Effects of angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients," has been cited a total of 236 times to date, placing it among the top five papers published in the past two years in the field of Clinical Medicine.
[read
complete interview]
View Salim Yusuf's record in
ISIHighlyCited.com.
in-cites.com,
ESI-Topics.com, and ScienceWatch.com
are editorial components
of Essential
Science Indicators.
Read more
about them.
|
